Special Issue "Muscle Selection for BoNT"
Deadline for manuscript submissions: closed (15 December 2017)
Muscle selection for botulinum toxin (BoNT) injections is a critical element in the safe and effective treatment for treating dystonia and spasticity with chemodenervation. Chemodenervation with BoNT injection has been a commonly used treatment strategy for various types of dystonias affecting cranial, cervical, trunk, and limb muscles. Symptomatic benefit for various dystonias or spasticity can occur with BoNT injections, though there are potential side effects such as weakness that should be minimized and can occur with improper muscle selection and BoNT dosing. When injecting with BoNT, one must carefully evaluate and select the muscles affected in the pattern of dystonia or spasticity demonstrated by the patient. Muscle selection is often based on a combination of patient history of symptoms and patterns of tightness; clinical observation of dystonic postures, tremor, or spasticity during examination; and sometimes electromyographic (EMG) findings of muscle overactivity or ultrasound localization. In this Special Issue of Muscle Selection for BoNT, the most up-to-date research and investigation on this topic are compiled, and the safety, efficacy, and effective best practice strategies are also discussed. Any format of BoNT can be presented here as used in the treatment of dystonia and/or spasticity, and articles discussing principles of muscle selection for BoNT, relevant anatomy, and techniques such as EMG identification, ultrasound, or electrical stimulation will be selected as well.
Dr. Jennifer G. Goldman
Dr. Codrin Lungu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Botulinum toxin
- Cervical dystonia
- Electrical stimulation
- Focal limb dystonia
- Generalized dystonia
- Occupational dystonia
- Physical therapy
- Writer’s cramp